Shaoxuan H. Wu - Publications

Prolonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity.

Journal: Cancer biology & therapy

Published: May 13, 2026

AI-guided discovery of the IRF4-PAICS-LDHA axis as a multitarget hub linking tumor metabolism to CD8+ T cell exhaustion in DLBCL.

Journal: NPJ precision oncology

Published: December 26, 2025

LCP2 mediates SUV39H1-driven cellular senescence-related chemoresistance in natural killer/T-cell lymphoma.

Journal: Cell death & disease

Published: October 18, 2025

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Journal: Aging

Published: August 01, 2023

SUV39H1 is a prognosis and immune microenvironment-related biomarker in diffuse large B-cell lymphoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 22, 2022

The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China.

Journal: Frontiers in nutrition

Published: June 29, 2022

GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.

Journal: Archives of biochemistry and biophysics

Published: March 07, 2021

sATP‑binding cassette subfamily G member 2 enhances the multidrug resistance properties of human nasal natural killer/T cell lymphoma side population cells.

Journal: Oncology reports

Published: December 13, 2019

miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.

Journal: Journal of cellular and molecular medicine

Published: October 24, 2018

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Journal: Cancer cell international

Published: April 02, 2018

Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: May 09, 2017

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.

Journal: PloS one

Published: October 23, 2016